Bloomberg
Business: Media / Entertainment / Sports |
National
3424 LEIGHTON RIDGE DR, Plano, TX 75025
Recent News About Bloomberg
View More
-
President Biden's First Year in Office: A Conversation with Former Pennsylvania Governor Rendell on December 3, 2021.
-
PITTSBURGH – The Pennsylvania Attorney General’s Office has come to terms with a telecommunications company accused of providing sub-standard DSL broadband Internet service to thousands of customers statewide over the last decade.
-
The Environmental Practice at global law firm Greenberg Traurig, LLP grew by close to 10 percent in 2019.
-
Cozen & O'Connor issued the following announcement on May 8.Cozen O’Connor announced they are signing on for Mansfield Rule 3.0 Certification.
-
The global law firm Jones Day ranks #1 for number of deals worldwide in both the Thomson Reuters and Bloomberg M&A league tables for the first half of 2018.
-
NEW YORK – Democratic state attorneys general, like Pennsylvania's Josh Shapiro, are getting free help from New York University School of Law to bolster their environmental causes, though a Commonwealth business advocacy group worries this results in important work being outsourced to an out-of-state entity.
-
CHICAGO – Recently, the City of Philadelphia initiated a major class-action lawsuit in Illinois federal court against a number of world financial institutions, claimed they violated federal antitrust law in colluding to prevent the purchase and sale of interest rate swaps (IRS).
-
The Pennsylvania Supreme Court this week allowed a multi-million dollar
-
WASHINGTON – Philadelphia's civil courts system has been named the nation's worst by the American Tort Reform Foundation for a second consecutive year.
-
Drug manufacturer Pfizer announced it has agreed to settle a consolidated civil case involving three women, two from Pennsylvania and one former Keystone State resident, who allege they developed breast cancer after taking medication designed to control menopause symptoms.
-
Three plaintiffs in a consolidated mass tort trial who had alleged their respective breast cancer diagnoses were directly related to their ingestion of hormone therapy medications have won the first part of their quest to hold a pharmaceutical giant responsible for their conditions.
